Nestlé SA said it agreed to buy Aimmune Therapeutics Inc., a biopharmaceutical company that earlier this year won approval for the first treatment for peanut allergies, in a deal valuing the company at $2.6 billion, including debt.
Nestlé previously had a large stake in Brisbane, Calif.-based Aimmune. The agreement to buy the rest of the company bulks up the Switzerland-based packaged-food giant’s decades-old health-science unit. It also adds a potential blockbuster prescription medication to its portfolio, amid a three-year...
Using health and nestle in the same sentence is an oxymoron. This is a disgusting company with a disturbing history. Especially with baby formula.
But we won't be able to afford it.
prettygurl_roxi is this the one?
I’m scared this medicine is going to end up in its food
Peanut allergies are caused by vaccines in the first place. See how they make money off these poisons.
The treatment is small doses of peanut protein lol. Some overcome some don't but it's potentially a lack of introduction at early ages and only introducing small amounts like a vaccine seem to overcome the allergy.
Congrats to those holding AIMT stock.
...just give babies some satay peanut sauce...easy peasy lemon squeazy
...just give babies some satay peanut sauce...easy peasy lemon squeazy
Trump: 'Make America Hate Again'! REMOVE the most corrupt presidency in US history, the Putin/Trump administration.
The Democratic Party has become the party of intolerance, censorship and Racism. Democrats have incited riots and promoted Marxist revolution, but offered NO protection to law abiding citizens. The country is waking to their evil and it has sealed their fate!
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »